# Telesair

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/telesair

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.telesair.com
- Total disclosed funding: $22M
- Latest round: Series A (Jan 10, 2023)
- Investors on record: 7

## About

Based in California, US, and founded in 2020 by its CEO, Bryan Liu, CTO, Tyler Li, and director, Don Lin, Telesair, Inc., operates as a manufacturing company that offers various medical devices used for improving health systems. In January 2023, Telesair, Inc., raised USD 22 million in seed funding led by Pasaca Capital, with participation from other investors such as Berkeley Catalyst Fund, Device of Tomorrow Capital, Honeywell Ventures, ShangBay Capital, Ultrastar Ventures LLC, and Zhencheng Capital.

The company offers various mobile respiratory care solutions to hospitals, long-term care and skilled nursing facilities, and rural health providers. The company uses sensor fusion technologies and innovative pneumatic solutions for patients suffering from various respiratory issues, like chronic obstructive pulmonary disease (COPD).

The company plans to use the January 2023 funding to boost the production of its Bonhawa Respiratory Humidifier.

## Funding rounds

- Series A, Jan 10, 2023, $22M — Honeywell Ventures, Zhencheng Capital, ShangBay Capital, Berkeley Catalyst Fund, Pasaca Capital, Device of Tomorrow Capital, Ultrastar Ventures LLC

## Investors

- Honeywell Ventures (https://capitalatlas.ai/funds/honeywell-ventures) — Series A
- Zhencheng Capital (https://capitalatlas.ai/funds/zhencheng-capital) — Series A
- ShangBay Capital (https://capitalatlas.ai/funds/shangbay-capital) — Series A
- Berkeley Catalyst Fund (https://capitalatlas.ai/funds/berkeley-catalyst-fund) — Series A
- Pasaca Capital (https://capitalatlas.ai/funds/pasaca-capital) — Series A
- Device of Tomorrow Capital (https://capitalatlas.ai/funds/device-of-tomorrow-capital) — Series A
- Ultrastar Ventures LLC — Series A